In vitro Bioequivalence for suspension ophthalmic [Regulatives / Guidelines]

posted by Weidson – Brazil, 2018-04-09 20:40 (1296 d 09:28 ago) – Posting: # 18658
Views: 1,419

Dear All,

Has anyone in this group ever performed an in vitro bioequivalence study with an ophthalmic suspension that was guided by the Guidance on Dexamethasone / tobramycin (reviewed June 2012, June 2013 and June 2016)? If yes, what is the acceptance criterion for bioequivalence? In the draft nothing is mentioned for the range of acceptance of the mortality rate of the microorganisms.

https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm308032.pdf

Thanks vary much.

Complete thread:

Activity
 Admin contact
21,758 posts in 4,550 threads, 1,544 registered users;
online 19 (0 registered, 19 guests [including 3 identified bots]).
Forum time: Wednesday 06:09 CEST (Europe/Vienna)

There ain’t no rules around here!
We’re trying to accomplish something!    Thomas Alva Edison

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5